AI ‘Simulants’ Could Save Time and Money on New Medications
Nov. 30, 2022 – Artificial intelligence is poised to make clinical trials and drug development faster, cheaper, and more efficient. Part of this strategy is creating "synthetic control arms" that use data to create “simulants,” or computer-generated “patients” in a trial. This way, researchers can enroll fewer real people and…
bubmagNovember 30, 2022